NEW YORK (TheStreet
) -- CHANGE IN RATINGS
upgraded to buy at TheStreet Ratings.
ACI downgraded at BMO from Market Perform to Underperform, BMO Capital said. $4 price target. Company's margins and balance sheet are weak, relative to the sector.
ANR downgraded at BMO from Outperform to Underperform, BMO Capital said. $5 price target. Company has a lot of debt, and margins are falling along with demand.
APC upgraded at Credit Suisse from Neutral to Outperform, Credit Suisse said. $90 price target. Tronox discount should disappear over time.
BID downgraded at Craig-Hallum from Buy to Hold, Craig-Hallum said. Company faces tough comps and is leveraged to slower growth in China. $35 price target.
CCF upgraded to buy at TheStreet Ratings.
CAKE upgraded at Goldman from Sell to Neutral, Goldman Sachs said. Estimates also boosted, given sustained sales trends.
CAM upgraded at Howard Weil from Market Perform to Outperform, Howard Weil said. Company can achieve near-term earnings guidance.
EAT upgraded at Piper from Underweight to Neutral, Piper Jaffray said. $32 price target. Sales trends are improving and the company is keeping a lid on costs.
GE downgraded at Morgan Stanley from Overweight to Equal-weight, Morgan Stanley said. Valuation call, based on a $22 price target.
HOT upgraded at MKM to Buy, MKM Partners said. $65 price target. Stock has lagged its peers, but near-term fundamentals remains strong and the company is buying back stock.
Helmerich & Payne
HP downgraded at Guggenheim to Neutral from Sell, Guggenheim said. Expectations for lower rig counts and margins.
MMM upgraded at Morgan Stanley to Overweight, Morgan Stanley said. $102 price target. Company should is leveraged to an ultimate recovery in electronics and the emerging markets.
NBR downgraded at Guggenheim to Neutral from Buy, Guggenheim said. US land rig count and day rates should weaken over the next three quarters.
Northwest Natural Gas
NWN downgraded at BofA/Merrill from Neutral to Underperform, Bank of America/Merrill Lynch said. Valuation call, based on a $45 price target.
OIS downgraded at Howard Weil from Focus Stock to Outperform, Howard Weil said. Company will have to raise guidance for the stock to continue moving higher.
PLL rated new Underperform at BofA/Merrill. $52 price target. Macro concerns may hamper aggressive restructuring efforts.
PNRA downgraded at Piper from Overweight to Underweight, Piper Jaffray said. $129 price target. Recent management changes add potential risks to the story.
PSX initiated at Oppenheimer as Outperform, Oppenheimer said. $42 price target. Leading downstream company.
QCOM upgraded at SocGen to Hold, Societe Generale said. Valuation call, based on a $57 price target.
SEM downgraded at BofA/Merrill from Buy to Neutral, Bank of America/Merrill Lynch said. $10 price target. Company is exposed to potential Medicare cuts.
SNDK downgraded at Baird to Neutral, Robert Baird said. $32 price target. Expect further weakness in NAND flash trends.
TXN downgraded at FBR from Market Perform to Underperform, FBR Capital Markets said. Estimates also cut, as the company will likely lower guidance. $24.50 price target.
STOCK COMMENTS / EPS CHANGES
CYBX numbers raised at Jefferies.
Shares of CYBX now seen reaching $58, Jefferies said. Estimates also raised on Chance of reversing coverage policy. Buy rating.
EBAY estimates increased at Benchmark through 2013, Benchmark said. Company is seeing higher sales growth. Buy rating and $45 price target.
FFIV numbers cut at Morgan Stanley.
FFIV estimates were reduced through 2014, Morgan Stanley said. Company is seeing weaker demand in Europe. Overweight rating and new $125 price target.
HIG numbers cut at UBS.
HIG now seen reaching $31, UBS said. Estimates also lowered on A&E, DAC, and Cats. Buy rating.
JDSU numbers lowered at Jefferies.
Shares of JDSU now seen reaching $13, Jefferies said. Estimates also lowered on recent vendor results and channel checks. Buy rating.
JNPR estimates, target reduced at Morgan Stanley.
Shares of JNPR now seen reaching $21, according to Morgan Stanley. Estimates also cut, given a weaker macro outlook. Overweight rating.
JPM estimates raised at Citigroup through 2013, Citigroup said. 2Q beat, higher assumed reserve releases, reduced CIO losses, and robust mortgage banking. Buy rating and $43 price target.
JPM estimates raised at UBS through 2013, UBS said. 2Q beat, capital management, and more reserve releases. $46 price target and Buy rating.
JPM target raised at Oppenheimer to $58, Oppenheimer said. Second quarter fundamentals on track. Outperform rating.
T target raised at Morgan Stanley to $36, according to Morgan Stanley. Company continues to execute well, especially in wireless. Overweight rating.
UNP target raised at Jefferies to $133, Jefferies said. Three more quarters of easy pricing comps. Buy rating.
VFC estimates trimmed at UBS through 2013, UBS said. Reflecting updated FX trends. Buy rating and $170 price target.
>To submit a news tip, email: email@example.com
READERS ALSO LIKE:
and become a fan on Facebook.